Introduction {#S1}
============

*Staphylococcus aureus* (*S. aureus*) is a highly-adaptable pathogen able to infect various tissues. Common manifestations of *S. aureus* infections range from mild skin and soft-tissue infections to invasive disease. Additionally, this pathogen has gained resistance against many anti-microbial drugs, leaving healthcare providers with few options for the treatment of infections ([@B5]; [@B6]). In the past, antimicrobial-resistant *S. aureus* infections were mostly associated with a recent hospital stay, but the rise in community-associated infections has steadily increased since the late 1990s ([@B5]; [@B19]). Drug-resistance combined with the lack of understanding of protective immunity to *S. aureus* has delayed the development of new therapeutics to treat this ubiquitous opportunistic pathogen.

The human neutrophil is essential for resolution of *S. aureus* infections, as individuals suffering from defects in neutrophil function are more susceptible to *S. aureus* infection ([@B22]). *S. aureus* has evolved many mechanisms to circumvent killing by these potent innate immune cells. The production of secreted virulence factors during pathogenesis is primarily controlled by the combined influence of two-component systems (TCSs) that sense the host environment and respond accordingly. Of these, the Sae TCS has been shown to be essential for evasion of human neutrophil killing ([@B44]; [@B13]). SaeR/S is immediately up-regulated following neutrophil phagocytosis and the histidine kinase, SaeS, is thought to specifically recognize neutrophil components ([@B43], [@B44]; [@B12]; [@B25]; [@B7]; [@B47]). The response regulator, SaeR, is activated following phosphorylation by SaeS and subsequently alters gene transcription by directly binding to a specific recognition sequence in the promoter region of numerous virulence genes including *nuc* and the bi-component leukotoxins *lukF* (PVL), *lukGH* (*lukAB*), and *hlgBC* that target human neutrophils ([@B33]; [@B34]; [@B24]). The upregulation of these genes facilitates *S. aureus* survival following neutrophil phagocytosis ([@B44]; [@B10]). However, the *sae* locus also includes two accessory genes, *saeP* and *saeQ*, whose gene products are not entirely understood. Previously published *in vitro* studies suggest these proteins form a complex with SaeS that deactivates SaeR ([@B15]). It has also been shown that increased expression of *saeP* impacts biofilm formation by increasing retention of high molecular weight DNA on the biofilm surface ([@B17]). The same study also demonstrated increases in *saeP* gene expression correlated with decreases in nuclease activity during biofilm development ([@B17]). Considering the importance of Sae during neutrophil interactions, we investigated the importance of *saeP* and *saeQ* during challenge with human neutrophils and *in vivo* using murine models of invasive disease and skin and soft-tissue infection. For these studies, we used *S. aureus* strain LAC, a USA300 isolate, as USA300 is the dominant clone causing community-associated methicillin resistant *S. aureus* (CA-MRSA) disease in the United States ([@B8]). Results demonstrate that deletion of *saeP* increased *S. aureus* cytotoxicity against neutrophils *ex vivo*. Moreover, the deletion of both *saeP* and *saeQ* markedly increased both nuclease expression in kidneys and overall mortality following intravenous infection.

Results {#S2}
=======

Generation of USA300 Isogenic Mutants Deficient in Either *saeP* or *saeQ* {#S2.SS1}
--------------------------------------------------------------------------

The Sae TCS is composed of four genes: *saeP, saeQ, saeR*, and *saeS* ([Figure 1A](#F1){ref-type="fig"}). Although *saeS* and *saeR*, encoding the sensory kinase and response regulator respectively, have been demonstrated to be essential in *S. aureus* virulence and pathogenesis ([@B44]; [@B33], [@B31]; [@B10]; [@B23], [@B24]; [@B47]; [@B13]), surprisingly little research has been performed on the two accessory genes of the Sae system, *saeP* and *saeQ*. Published data indicate that *saeP* encodes a lipoprotein anchored to the exterior surface of the plasma membrane, whereas *saeQ* encodes a transmembrane protein ([@B15]; [@B17]). To investigate the roles of these genes, we utilized a *saeP* deletion mutant (USA300Δ*saeP*) generated previously in [@B17], and deleted the first third of *saeQ* (164 bp) in USA300 LAC using allelic replacement to create an isogenic *saeQ* deletion mutant (USA300Δ*saeQ*) that preserves the P3 promoter ([@B1]; [@B16]). Absence of *saeP* and *saeQ* genes were verified by PCR ([Figure 1A](#F1){ref-type="fig"}). Importantly, deletion of *saeP* or *saeQ* did not substantially impact *saeR* and *saeS* gene expression. TaqMan® real-time RT-PCR analyses indicated a slight increase in *saeR* transcript levels in the USA300Δ*saeP* mutant at both mid-exponential (ME) and early stationary (ES) phases of growth relative to USA300. This trend was also established for the expression of *saeS* in USA300Δ*saeP* at ME phase. Expression of *saeR* and *saeS* were essentially unchanged in USA300Δ*saeQ* relative to USA300 at ME but were decreased during ES ([Figure 1B](#F1){ref-type="fig"}). Basal expression from the P3 promoter is likely unaffected by deletion of *saeQ* since the deletion ends 108 base pairs upstream of the P3 promoter ([@B16]) and ME expression is similar to USA300. When the Sae TCS is activated, transcription from the P1 promoter increases ([@B30]; [@B39]). Therefore, when the system activates in ES ([@B10]), mRNA transcripts containing the *saeQ* deletion may have reduced stability since the mRNA secondary structure has recently been shown to be important ([@B26]). Nevertheless, this is not expected to affect the activation of SaeR/S target genes, as overexpression of *saeRS* does not alter the expression profile of the Sae-regulon ([@B25]; [@B24]). Additionally, USA300Δ*saeP* and USA300Δ*saeQ* strains showed no significant growth defects compared to USA300 ([Figure 1C](#F1){ref-type="fig"}).

![Generation of an isogenic *saeQ* mutant. **(A)** (Above) Schematic of the four genes of the *sae* locus. Bent arrows indicate transcriptional start sites described in [@B30], [@B39], and [@B16]. (Below) Results of agarose gel electrophoresis showing USA300 mutants lacking *saeP* (from [@B17]), *saeQ*, and respective complemented strains. Letters at the bottom of the gel indicate the *sae* gene targeted by PCR analysis. Primer sequences are included in [Table 1](#T1){ref-type="table"}. **(B)** TaqMan® RT-PCR analysis of *saeS* and *saeR* transcript levels in USA300Δ*saeP* and USA300Δ*saeQ* relative to USA300 at mid-exponential phase (ME) and early stationary phase (ES). Transcript levels in samples were analyzed in triplicate and results are from two independent experiments. **(C)** *In vitro* growth of USA300, USA300Δ*saeP*, USA300Δ*saeQ*, and USA300Δ*saePQRS* ([@B10]) measured by optical density at 600 nm (OD~600~) (left) and colony forming units (CFUs) (right). Timepoints are indicated by the bracket on the OD~600~ plot. Arrows indicate time points for RNA harvest (used in **B**). Data are presented as the mean ± SEM of seven independent experiments. n.d., not detected.](fmicb-11-00561-g001){#F1}

###### 

Primers used to generate *S. aureus* mutant strains, respective complemented strains, and TaqMan® primer and probe sequences.

  **Primer**                                            **Sequence**                                                   **Description**                       **References**
  ----------------------------------------------------- -------------------------------------------------------------- ------------------------------------- ----------------
  **Construction of USA300Δ*saeP* and USA300Δ*saeQ***                                                                                                        
  Forward                                               5′-GTTGTTGAATTCACCTGATACATTACAGACC-3′                          600 bp upstream of *saeP*             [@B17]
  Reverse                                               5′-CAGAAATTGAGTACTAGATCTGTATTCATGCTAACTCCTCATTTC-3′            Upstream of *saeP* plus overlap       [@B17]
  Forward                                               5′-GAATACAGATCTAGTACTCAATTTCTGAGTTAAACTTTTATTTACAAC-3′         Downstream of *saeP* plus overlap     [@B9]
  Reverse                                               5′-GTTGTTGGTACCAAGAAACTAGCAGCATATGC-3′                         600 bp downstream of *saeP*           [@B9]
  Forward                                               5′-GTTGTTGAATTCCCTAACAGGTACATTCAGTTC-3′                        EcoR1, 600 bp upstream of *saeQ*      [@B9]
  Reverse                                               5′-GCGAGTACTAGATCTCATTCTTTCTATTATTGTGTGTAATTTATAT-3′           Upstream of *saeQ* plus overlap       [@B9]
  Forward                                               5′-AGAATGAGATCTAGTACTCGCAAATATAGTTGCACATAC-3′                  165 bp into *saeQ* plus overlap       [@B9]
  Reverse                                               5′-GTTGTTGGTACCGATGGTATATGTTGTAAAGCTCTC-3′                     *Kpn*I, 900 bp downstream of *saeQ*   This work
  Forward                                               5′-TAATTTAGCGCCGCCGAAGA-3′                                     *saeP*                                This work
  Reverse                                               5′-TTTTTAGCAGCTGGTGCTGT-3′                                     *saeP*                                This work
  Forward                                               5′- CTCTGTTCTTACGACCTCTAAAGTAAT-3′                             *saeQ*                                This work
  Reverse                                               5′-GTTTAGTACCAGTCATCGCTAACA-3′                                 *saeQ*                                This work
  Forward                                               5′-GGTGGTGAATTCTTAACTTATCAAATTGAAGAAATGAGGAGTTAGC-3′           pEPSA5-*saeP*-EcoR1                   This work
  Reverse                                               5′-ACCACCGGATCCAATTGATTATTTTAATTTAGCGCCGCC-3′                  pEPSA5-*saeP*-*Bam*HI                 This work
  Forward                                               5′-GGTGGTGAATTCTTATATAAATTACACACAATAAATAGAAAGAATGTGAACATC-3′   pEPSA5-*saeQ*-EcoR1                   This work
  Reverse                                               5′-GGTGGTGGATCCTGTTCATCATCCACGATCAGTAAGT-3′                    pEPSA5-*saeQ*-*Bam*HI                 This work
  **Taqman® primer/probe sequences**                                                                                                                         
  Forward                                               5′-CACCTAACAGGTACATTCAGTTCTA-3′                                *saeP* primer                         This work
  Reverse                                               5′-GGTAGACGTATAAATCTGGACCTTT-3′                                *saeP* primer                         This work
  Probe                                                 5′-ACGGTGAAACTGTTGAAGGTAAAGCTGA-3′                             *saeP* probe                          This work
  Forward                                               5′-CACCAGAGTGGTATAAGTGGTT-3′                                   *saeQ* primer                         This work
  Reverse                                               5′-CAAAGCCTCCAAAGAAACTAGC-3′                                   *saeQ* primer                         This work
  Probe                                                 5′-TTGTTGTCCCACTCGGAGAGATTGC-3′                                *saeQ* probe                          This work

Deletion of *saeP* Increases Bacterial Survival Following Neutrophil Phagocytosis {#S2.SS2}
---------------------------------------------------------------------------------

SaeS has been shown to be activated by neutrophil phagocytosis and associated components including alpha-defensin and hydrogen peroxide ([@B43]; [@B12]; [@B46]). Moreover, deletion of *saeR/S* has been shown to significantly decrease *S. aureus* survival and cytolytic capacity following neutrophil phagocytosis ([@B44]; [@B10]). However, nothing is known about how SaeP and SaeQ contribute to staphylococcal neutrophil evasion. To determine the role of these accessory proteins during interaction with human neutrophils, we initially evaluated phagocytosis and killing of USA300Δ*saeP*, USA300Δ*saeQ*, USA300Δ*saePQRS* ([@B10]), or USA300. Importantly, there were no significant differences in the uptake of these strains by human neutrophils ([Figures 2A,B](#F2){ref-type="fig"}), consistent with previous observations using Δ*saeR/S* strains that have shown the SaeR/S system has no significant impact on neutrophil phagocytosis ([@B44]; [@B13]). Next, we assessed *S. aureus* survival after neutrophil phagocytosis. After 30 min, we measured very modest increases in the survival of the *saeP* and *saeQ* mutant strains relative to the parental wild-type strain. However, deletion of *saeP* significantly increased bacterial survival compared to USA300 5-h after phagocytosis. There was also a noticeable although not statistically significant increase in survival of USA300Δ*saeQ* compared to USA300 at 5 h post-neutrophil exposure. We measured a significant reduction in survival of USA300Δ*saePQRS* strain at both timepoints, confirming the importance of *saeR/S* for *S. aureus* survival following neutrophil phagocytosis as previously observed ([@B44]; [Figure 2C](#F2){ref-type="fig"}).

![Deletion of *saeP* significantly increases *S. aureus* survival and toxicity during neutrophil interaction. **(A)** Percent *S. aureus* ingested by neutrophils. Samples were collected on an Image Stream® Imaging Flow Cytometer and *S. aureus* internalization was analyzed using the IDEAS software® as described in Materials and Methods for three independent experiments. **(B)** Numbers of ingested *S. aureus* per PMN are shown. The average number of *S. aureus* detected to be ingested per PMN is ∼ 10 for all strains. Data are presented as the mean ± SEM of three independent experiments. **(C)** Percent survival for the indicated strains and timepoints is shown. Bacterial survival is significantly increased in USA300Δ*saeP* compared to USA300 at 5 h following phagocytosis. Survival was calculated with the following equation: (CFU + PMN at time~n~/CFU + PMN at time~0~) × 100 (as in [@B43]). Data are presented as the mean ± SEM of six independent experiments. At 0.5 h, USA300Δ*saePQRS* was significantly different from USA300 \*\**P* ≤ 0.001 using one-way ANOVA with Tukey's post-test. At 5 h, \**P* ≤ 0.05 and \*\**P* ≤ 0.001 relative to USA300 using one-way ANOVA and Tukey's post-test. **(D)** Supernatants from USA300Δ*saeP* cultures cause significantly more neutrophil plasma membrane damage compared to supernatants from USA300 cultures. *S. aureus* strains were grown to early stationary phase, supernatants harvested as described in Materials and Methods (diluted 1:10), and incubated with neutrophils for 1 h. Propidium iodide (PI) uptake was assessed by flow cytometry. Data are presented as the mean ± SEM of five independent experiments. \**P* ≤ 0.05, \*\*\*\**P* ≤ 0.0001 using one-way ANOVA with Tukey's post-test. ctl, neutrophil-only control. ns, not significant.](fmicb-11-00561-g002){#F2}

Deletion of *saeP* Increases Production of Neutrophil Cytolytic Factors {#S2.SS3}
-----------------------------------------------------------------------

SaeR/S up-regulates the transcription of numerous secreted virulence factors including the bi-component leukotoxins LukG/H, PVL, and HlgB/C that specifically target and disrupt the neutrophil plasma membrane ([@B44]; [@B33]; [@B40]; [@B42]; [@B10]; [@B46]). Since USA300Δ*saeP* cells demonstrated increased survival following phagocytosis, we hypothesized that *saeP* might influence the production of secreted cytolytic factors (i.e., ability to permeabilize neutrophils). Indeed, neutrophils exposed to filtered supernatants taken from ES cultures of the USA300Δ*saeP* mutant exhibited significantly more plasma membrane damage than neutrophils exposed to supernatants taken from cultures of USA300 as determined by propidium iodide uptake ([Figure 2D](#F2){ref-type="fig"}). Supernatants from USA300Δ*saeQ* showed no significant differences in cytolytic activity compared with USA300. Confirming previous observations with Δ*saeR/S* strains, neutrophils exposed to the supernatants from USA300Δ*saePQRS* cultures showed significantly reduced plasma membrane damage compared to results from exposure to culture supernatants from all other *S. aureus* strains tested and similar to that of neutrophils not exposed to *S. aureus* supernatants ([@B44]; [@B10]). USA300Δ*saeP* complemented with *saeP* in trans reduced the cytotoxicity of this strain to levels that paralleled USA300 ([Supplementary Figure S1A](#FS1){ref-type="supplementary-material"}).

Deletion of *saeP* Increases Transcript Abundance of Several Leukotoxins {#S2.SS4}
------------------------------------------------------------------------

The SaeR/S system is essential for transcriptional regulation of virulence factors known to impact neutrophil function ([@B44]; [@B25]; [@B33]; [@B10]; [@B46]; [@B13]). Since the USA300Δ*saeP* strain demonstrated increased survival following phagocytosis by neutrophils, and supernatants from USA300Δ*saeP* had increased cytolytic activity toward neutrophils, we profiled the transcript abundance of select SaeR/S-regulated virulence factors known to impact neutrophil viability. During mid-exponential phase (ME) we measured subtle increases in *lukG* transcript abundance in both USA300Δ*saeP* and USA300Δ*saeQ* mutant strains, as well as a subtle increase in *lukF*-PVL transcript abundance levels in USA300Δ*saeP* ([Figure 3A](#F3){ref-type="fig"}). Importantly, we measured more pronounced increases in *lukG*, *lukF-PV*, *hlgA*, *hlgB*, and *hlg*C transcript abundance in USA300Δ*saeP* relative to USA300 during early stationary (ES) phase. Transcript abundance of all select virulence genes was reduced in the USA300Δ*saePQRS* mutant in accordance with previous observations examining the influence of Sae on virulence gene transcription ([@B44]; [@B33]; [@B10]; [@B46]). Expression of *saeP* in trans in the USA300Δ*saeP* strain reduced transcript abundance and cytotoxicity to levels at or below those measured in USA300 ([Supplementary Figures S1B,C](#FS1){ref-type="supplementary-material"}).

![USA300Δ*saeP* demonstrates increased transcript abundance of several known SaeR/S-virulence factors. **(A)** Mean fold-change of known SaeR/S-regulated virulence genes in USA300Δ*saeP* and USA300Δ*saeQ* relative to USA300 is shown. Transcript abundance was measured using TaqMan® RT-PCR at mid-exponential (ME; left) and early stationary (ES; right) phases of *in vitro* growth. Transcripts were normalized to *gyrB* and calibrated to transcript abundance in USA300. Data are from at least two independent experiments. **(B)** The USA300Δ*saeP* strain of *S. aureus* produces significantly more Panton Valentine Leukocidin (PVL) compared to USA300. (Top) Representative Western blot of PVL protein in supernatants from *S. aureus* grown overnight. (Bottom) Quantification of PVL was calculated using densitometry as described in Materials and Methods. Data shown are amounts relative to USA300 and presented as the mean ± SEM of three independent experiments. \**P* ≤ 0.05 One-Way ANOVA with Tukey's post-test. n.d., not detected.](fmicb-11-00561-g003){#F3}

Supporting transcript analysis of *lukF-PV*, secreted PVL in overnight culture supernatants was significantly increased in the USA300Δ*saeP* strain compared to USA300 ([Figure 3B](#F3){ref-type="fig"}). As anticipated, PVL was essentially undetectable in culture supernatants from the Δ*saePQRS* mutant, demonstrating a strong dependency on Sae for production of PVL ([Figure 3B](#F3){ref-type="fig"}).

Deletion of *saeQ* Attenuates Mortality in Mice Following Intravenous Infection {#S2.SS5}
-------------------------------------------------------------------------------

To investigate the individual roles of *saeP* and *saeQ* during staphylococcal disease, we used a well-established model of acute bacteremia ([@B44]; [@B33]). Mice (groups of 10) were infected intravenously with 1 × 10^7^ CFUs of either *S. aureus* USA300, USA300Δ*saeP*, USA300Δ*saeQ*, or USA300 Δ*saePQRS*. Consistent with previous studies ([@B33]), ∼65% of the mice infected with USA300 died within 48 h, and on average fewer than 10% of the mice survived 72 h post-infection. Although there were no significant differences in the mortality of mice challenged with USA300Δ*saeP* compared with USA300, nearly all mice infected with USA300Δ*saeQ* survived 72 h post-infection ([Figure 4](#F4){ref-type="fig"}). All mice challenged with Δ*saePQRS* survived, congruent with previous studies ([@B44]; [@B33]) and demonstrating the critical role of the Sae system following bloodstream infection ([Figure 4](#F4){ref-type="fig"}).

![*saeQ* contributes to staphylococcal disease during bacteremia. Groups of 10 C57BL/6 mice were infected intravenously via the tail vein with 1 × 10^7^ CFU of the indicated *S. aureus* strains. Survival curves are from two independent experiments \*\*\*\**P* \< 0.0001, log-rank (Mantel-Cox) test.](fmicb-11-00561-g004){#F4}

SaeR/S is also critical for *S. aureus* pathogenesis during murine skin and soft-tissue infection (SSTI) ([@B44]; [@B33], [@B31]). To investigate the importance of SaeP and SaeQ in SSTI, BALB/c and C57BL/6 mice were infected subcutaneously with 1 × 10^7^ CFUs of either USA300 or our isogenic mutants, and abscess area was monitored for 10 days. While we measured a significant decrease in the abscess area of mice infected with the USA300Δ*saePQRS* mutant compared to USA300, we detected no significant differences in abscess size or incidence of dermonecrosis when either *saeP* or *saeQ* were deleted ([Supplementary Figures S2A,B](#FS2){ref-type="supplementary-material"}). Taken together, although Sae TCS activity is required for full virulence in both bacteremia and SSTI, our data indicate SaeP and SaeQ are dispensable during SSTI, but SaeQ appears to be important during bacteremia.

USA300Δ*saePQ* Mimics the USA300Δ*saeP* Phenotype During Neutrophil Interaction, but Significantly Increases Mortality Following Intravenous Infection in Mice {#S2.SS6}
--------------------------------------------------------------------------------------------------------------------------------------------------------------

Due to our observations that USA300Δ*saeP* demonstrates increased ability to survive neutrophil phagocytosis and that USA300Δ*saeQ* had increased (although not significant) survival following neutrophil phagocytosis, we wondered whether a double mutant deficient in both *saeP* and *saeQ* might exhibit an enhanced phenotype in the aforementioned neutrophil assays. To test this, we first deleted the entire *sae* locus in LAC using allelic exchange and then introduced *saeRS* driven by their native P3 promoter into the chromosome at the *geh* locus using the single copy integration plasmid pCL55 ([@B23]). The resulting strain (hereafter referred to as USA300 Δ*saePQ*) exhibited reduced expression of *saeR/S* during exponential growth *in vitro* ([Supplementary Figures S3A,B](#FS3){ref-type="supplementary-material"}). This could be due to the absence of transcriptional readthrough from the stronger P1 promoter. Regardless, the USA300 Δ*saePQ* double mutant is still capable of inducing SaeR/S-mediated virulence gene expression in response to human neutrophil peptide-1 (HNP-1) exposure ([Supplementary Figure S3C](#FS3){ref-type="supplementary-material"}). Compared to USA300, USA300 Δ*saePQ* exhibited a significant increase in both bacterial survival following phagocytosis as well as increased cytotoxicity toward neutrophils. This increase in virulence was consistent with observations made with USA300Δ*saeP* in both neutrophil survival and plasma membrane damage ([Figure 5](#F5){ref-type="fig"} compared to [Figure 2](#F2){ref-type="fig"}). We measured similar fold-changes in the expression of Sae-dependent virulence genes in USA300Δ*saePQ* (also similar to those observed in USA300Δ*saeP*) during ES compared to USA300 (compare *lukG* and *lukF-PVL* in [Figure 5](#F5){ref-type="fig"} and [Figure 2](#F2){ref-type="fig"}). As we saw in the SSTI model following challenge with the USA300Δ*saeP* or USA300Δ*saeQ* mutants, mice challenged with the USA300Δ*saePQ* mutant showed no significant differences in abscess area compared to USA300 ([Figure 5D](#F5){ref-type="fig"}). However, we found that intravenous infection with the USA300Δ*saePQ* double mutant led to a significant increase in mortality compared to infection with USA300 in the bacteremia model ([Figure 6](#F6){ref-type="fig"}).

![USA300Δ*saePQ* demonstrates enhanced survival following neutrophil phagocytosis. **(A)** USA300Δ*saePQ* survives neutrophil killing significantly better than USA300 after 5 h incubation. Data are presented as the mean ± SEM of eight independent experiments. **(B)** PMN plasma membrane damage was significantly increased in neutrophils infected with USA300Δ*saePQ* compared to infection with USA300 (neutrophil: bacteria ratio of 1:5). Propidium iodide uptake was assessed at 3 h post-infection by flow cytometry and indicate USA300Δ*saePQ* produces significantly more cytolytic proteins in the supernatants than USA300. Data are presented as the mean ± SEM of five independent experiments. **(C)** Transcript abundance of *lukG* is increased in USA300Δ*saePQ* relative to expression in USA300 at early stationary phase. Gene transcripts were normalized to *gyrB* and calibrated to the expression levels of USA300. **(D)** Deletion of *saePQ* did not significantly impact abscess area. C57BL/6 mice were infected subcutaneously with 1 × 10^7^ CFU of *S. aureus*. Abscess area was measured daily and results shown are the average of five mice per group. \**P* ≤ 0.05, \*\**P* ≤ 0.01, \*\*\**P* ≤ 0.001, \*\*\*\**P* ≤ 0.0001 via one-way ANOVA Tukey's post-test. Data are presented as the mean ± SEM.](fmicb-11-00561-g005){#F5}

![Deletion of *saePQ* enhances the virulence in *S. aureus* in a mouse model of systemic infection. Survival curves for C57BL/6 mice (*n* = 13/group) challenged with either 1 × 10^7^ CFU *S. aureus* or USA300 or USA300Δ*saePQ* via tail vein injection. Data shown are death from infection and euthanasia (for exceeding scores on the welfare rubric) during the 72 h endpoint. Data are from two independent experiments. \*\*\*\**P* \< 0.0001, log-rank (Mantel-Cox) test.](fmicb-11-00561-g006){#F6}

To investigate if the increased mortality in mice challenged with the USA300Δ*saePQ* mutant was due to increased expression of SaeR/S-dependent virulence factors, we infected mice with either USA300 or USA300Δ*saePQ* mutant carrying an integrated *nuc-gfp* translational fusion ([@B2]). Three days post-infection, groups of three-eight C57BL/6 mice were euthanized. Kidneys were harvested, fixed and embedded, and examined using confocal microscopy. Consistent with previous results, USA300 formed clearly-defined abscesses containing a nidus of staphylococci also referred to as a staphylococcal abscess community (SAC). These bacteria exhibit spatial regulation of *nuc-gfp* as we previously reported ([@B2]). That is, we detected strong expression of *nuc-gfp* in the core of the SAC and muted expression on the periphery of the SAC. On the other hand, the USA300Δ*saePQ* mutant failed to form discrete, well-formed abscesses. Instead, widespread infiltration of the renal tissues was apparent, and the *nuc-gfp* reporter was highly expressed in bacteria on the periphery of the lesions ([Supplementary Figure S4](#FS4){ref-type="supplementary-material"}). Taken together, these data indicate that the *saePQ* mutant phenocopies a *saeP* mutant during human neutrophil interaction, and lack of both gene products impacts pathogenesis and virulence expression during bacteremia.

Discussion {#S3}
==========

The Sae TCS of *S. aureus* contributes to the expression and production of virulence and immunomodulatory factors that are essential for *S. aureus* neutrophil evasion and pathogenesis ([@B44]; [@B33]; [@B40]; [@B10]; [@B46]). Much is known about the molecular genetics of activation of the SaeS bifunctional kinase/phosphatase and the SaeR response regulator. However, despite its discovery over two decades ago, relatively little is known about how the auxiliary proteins SaeP and SaeQ contribute to Sae TCS activity and staphylococcal disease. Herein, we utilized *saeP* and *saeQ* single and double mutant strains to characterize the role of these accessory proteins using both *ex vivo* human neutrophil assays and *in vivo* mouse models of infection. Our results suggest that SaeP acts as a regulator of SaeR/S-dependent virulence during challenge with human neutrophils. Although no statistically significant phenotype could be established for USA300Δ*saeQ* following interactions with human neutrophils, we did note an increase in the survival of mice following intravenous infection with this strain, suggesting that SaeQ contributes to SaeR/S signaling during bacteremia.

Our findings support previously-published *in vitro* data ([@B15]; [@B17]) suggesting SaeP may regulate SaeR/S-dependent effectors during human neutrophil encounters. The observation that the USA300Δ*saeP* strain is more cytotoxic against neutrophils and exhibits increased bacterial survival following phagocytosis suggest that the impact of SaeP on SaeR-target genes is specific and likely dependent on environmental cues. The observation that there was no additive effect of enhanced survival following neutrophil phagocytosis of USA300Δ*saePQ* compared to USA300Δ*saeP* also supports a specific role for *saeP* during interaction with human neutrophils. Future studies will continue to characterize the role of SaeQ.

*S. aureus* uses secreted nuclease (Nuc) along with secreted adenosine synthase (AdsA) to escape neutrophil extracellular traps (NETs) ([@B41]). Increasing Nuc expression and production in kidney tissues may increase the production of deoxyadenosine, and this could trigger caspase-3-mediated immune cell death ([@B41]). In USA300 LAC, SaeP down-regulated *nuc-gfp* gene expression via SaeR/S ([@B17]). Thus, the hypervirulent phenotype of the *saePQ* double mutant during acute bacteremia is not unexpected. However, it is unclear why the *saeP* and *saeQ* single mutants behave differently. Since we used a purified diet for the *in vivo nuc-gfp* mouse reporter studies, we cannot exclude the possibility that this diet amplifies mild phenotypes observed in mice challenged with the *saeP* and *saeQ* mutant strains. It would be interesting to examine the impact of SaeP and SaeQ during chronic kidney infections in mice. The observation that the *saeQ* mutant is highly attenuated was unexpected. Given the known protein-protein interactions between SaeQ and SaeS, it is possible that the stability and/or activity of SaeS is compromised in this mutant. Indeed, SaeQ is required for hyperactive SaeS (SaeS^L18P^) stability in strain Newman ([@B16], [@B15]). Clearly there is still much to learn about the function of these proteins; only a few studies investigate SaeP and/or SaeQ.

Recently, [@B17] confirmed the cellular localization of SaeP on the cell surface as a lipoprotein, and that its C-terminal domain is facing the extracellular matrix. SaeQ is predicted to be a membrane protein with three membrane-spanning domains, and forms a complex with SaeP and SaeS in the membrane ([@B15]). A conserved domain search revealed that the C-terminal portion of SaeP looks like a member of the DM13 superfamily of proteins. Because of its association with the DOMON domain, is thought DM13 proteins might be involved in electron transfer. SaeQ is predicted to be a member of the DoxX family of proteins similar to *Bacillus subtilis* putative oxidoreductases MhqP and CatD, and *Escherichia coli* inner membrane proteins YphA and YqjF ([@B14]). The Sae system is responsive to cellular respiratory status but the mechanism is unclear. One model posits that inhibition of respiration by oxygen depletion or chemical disruption of the electron transport chain by reactive oxygen species or nitrosative species could lead to a block in the respiratory chain and a buildup of reduced quinones in the membrane, activating Sae activity ([@B27]). It is conceivable SaePQ sense this perturbation, go inactive, and promote SaeS kinase activity. Alternatively, SaeP possesses a pI of ∼8 and is capable of binding negatively charged eDNA in acidic environments ([@B17]). It is tempting to speculate that a physical interaction with neutrophil NET DNA induces some conformational change in SaeP that hinders its ability to stimulate phosphatase activity of SaeS in the staphylococci nearest the neutrophil cuff. Either repressive mechanism could explain the apparent increased *nuc-gfp* expression in the periphery of lesions formed by the *saePQ* double mutant ([Supplementary Figure S4](#FS4){ref-type="supplementary-material"}, compare panels D vs. A). Increased nuclease expression may result in increased virulence during immune cell encounter and could explain why no discrete abscesses could be found when mice were infected with the *saePQ* double mutant ([Supplementary Figure 4](#FS4){ref-type="supplementary-material"}).

*In vivo* observations made with USA300Δ*saePQ* suggest that neither *saeP* nor *saeQ* influence virulence factors that contribute to murine skin and soft-tissue abscess severity. Inasmuch as alpha-toxin (Hla) is known to play a key role in dermonecrosis caused by USA300 during murine skin and soft tissue infection ([@B18]), results from the skin infection model are in agreement with our gene expression data that demonstrate *sae*P and *sae*Q do not influence *hla* transcript abundance ([Supplementary Figures S2A,B](#FS2){ref-type="supplementary-material"}). However, the observation that USA300Δ*saePQ* is hypervirulent in the bacteremia model is more difficult to explain with our current data. Potentially, different host niches have varying levels of different activating cues and levels of Sae TCS activity. Clearly, additional studies are needed to precisely determine the importance and impact of SaeP and SaeQ at these sites *in vivo* and to identify conditions that influence their expression and function.

Materials and Methods {#S4}
=====================

Bacterial Strains and Culture {#S4.SS1}
-----------------------------

All *S. aureus* strains used in this study are derivatives of the clinically-relevant CA-MRSA strain USA300 (LAC) that was previously cured of the plasmid encoding erythromycin resistance ([@B3]). Unless otherwise indicated, overnight and subculture media consisted of tryptic soy broth (TSB) (EMD Millipore; Darmstadt, Germany) supplemented with 0.5% (w/v) glucose. When needed, antibiotics were included in the medium at the following concentrations: ampicillin (Amp), 50 μg ml^--1^; chloramphenicol (Cm), 5 μg ml^--1^; and erythromycin (Erm), 5 μg ml^--1^. Subcultures were created using 1:100 dilution of the overnight culture. For the growth curves, OD~600~ readings were collected every 0.5 h using a Nanodrop 2000C UV-Vis Spectrophotometer (ThermoFisher Scientific; Wilmington, DE, United States) or an Amersham Ultraspec 2100 pro UV-visible spectrophotometer and colony forming units (CFUs) were enumerated after incubation overnight at 37°C with 5% CO~2~ as described ([@B43]).

Generation of Mutant Strains {#S4.SS2}
----------------------------

Construction of the isogenic *saeQ* deletion mutant was performed using allelic exchange and pJB38 plasmid ([@B1]; [@B4]). The *saeP* mutant was constructed previously ([@B17]). To construct the *saePQ* strain, we first deleted the entire *sae* operon using pKOR1-sae ([@B1]). Next, we transduced the strain to chloramphenicol resistance, moving in the P~saeP3~-*saeRS* construct (*saeRS* under the control of their native promoter, cloned into pCL55 and integrated into the *geh* locus, Cm^R^). Then, we integrated the *nuc-gfp* reporter as described by allelic exchange ([@B2]). Briefly, DNA fragments upstream and downstream of the gene or gene fragment of interest were amplified using primers listed in [Table 1](#T1){ref-type="table"}, purified by agarose gel electrophoresis, then combined in a two-step overlap PCR reaction and cloned into pJB38 ([@B10]). Δ*saePQRS* was made previously in [@B10]. The resulting plasmid was transformed sequentially into *Escherichia coli* (*E. coli*) strain ER2566 (New England Biolabs), then *S. aureus* strain RN4220, and the final background USA300 LAC ([@B9]). Final mutants were verified by PCR amplification of the chromosomal region of interest and DNA sequencing. Lack of *saeP* and *saeQ* in the mutant strains were verified by PCR and agarose gel electrophoresis.

For complementation strains, the *saeP* and *saeQ* genes were cloned into the pEPSA5 plasmid ([@B11]) using restriction enzymes (EcoR1 and BamH1) and primers listed in [Table 1](#T1){ref-type="table"}. The resulting plasmids (pEPSA5-*saeP*comp and pEPSA5-*sae*Qcomp) drive expression of the *sae* genes from the xylose-inducible P~xyl~ promoter. To induce expression, the medium was supplemented with 2% (w/v) xylose in experiments involving these strains as indicated ([@B11]). These plasmids were transformed into electrocompetent *E. coli* GM2163 (New England Biolabs), then directly into the respective mutant *S. aureus* strain (USA300Δ*saeP* and USA300Δ*saeQ*) via *E. coli* strain IM08B ([@B29]) and called pEPSA5-*saeP*comp and pEPSA5-*saeQ*comp. The resulting strains were confirmed using PCR amplification and agarose gel electrophoresis, and presence of transcript abundance verified by TaqMan RT-PCR as done previously ([@B44]; [@B33]; [@B10]).

Neutrophil Isolation {#S4.SS3}
--------------------

Heparinized venous blood from healthy donors was collected in accordance with a protocol approved by the Institutional Review Board for Human Subjects at Montana State University. All donors provided written consent to participate in the study. Human neutrophils \[polymorphonuclear leukocytes (PMNs)\] were isolated under endotoxin-free conditions (\<25pg ml^--1^) as previously described ([@B43], [@B44]). Purity (\<1% PBMC contamination) and viability (\<2% propidium iodide positivity) of neutrophil preparations were assessed by flow cytometry on a FACS Calibur instrument and BD Biosciences Cell Quest Pro software (version 0.3.3f1b).

Image Stream Phagocytosis Assay {#S4.SS4}
-------------------------------

Neutrophil phagocytosis was determined using a fluorescence-based flow cytometry/microscopy method described previously ([@B36]). Briefly, *S. aureus* was grown to mid-exponential phase, opsonized with 50% (vol/vol) normal human serum and labeled with 750 μL fluorescein isothiocyanate (FITC) at a final concentration of 0.002 mg mL^--1^. *S. aureus* strains were combined with neutrophils at a multiplicity of infection (MOI) of 10:1 (bacteria: neutrophils) in 96-well plates coated with human serum coated (20% v/v). Phagocytosis was synchronized by centrifugation as described ([@B43]) and incubated at 37°C with 5% CO~2~ for 30 min. Cells were fixed in 2% (v/v) Periodate-Lysine-Paraformaldehyde (PLP) for 10 min at room temperature ([@B35]). PLP was then washed away and antibodies/stains were applied: mouse anti-human CD11b antibody-PE (BD; Franklin Lakes, NJ, United States) and nuclear stain DRAQ5^TM^ (ThermoFisher Scientific; Wilmington, DE, United States). Cells were washed and suspended in 50 μL sterile Dulbecco's phosphate buffered saline (DPBS) and analyzed by an ImageStream®X Mark II Imaging Flow Cytometer (Millipore Sigma) the following day. Phagocytosis was analyzed using IDEAS® software (AMNIS®, Millipore Sigma, Darmstadt, Germany) where cell images were gated to include neutrophils that were both in focus and singlets. Of these cells, images fluorescing both neutrophil and *S. aureus* membrane dyes were analyzed using the AMNIS internalization wizard ([@B36]).

Bacterial Survival Assay {#S4.SS5}
------------------------

Bacterial survival was assessed following synchronized phagocytosis as previously described ([@B43]). Briefly, *S. aureus* strains were grown to mid-exponential phase, opsonized in 50% (v/v) normal human serum, and combined with neutrophils in 96-well plates coated with 20% (v/v) human serum (MOI of 10:1) and incubated at 37°C with 5% CO~2~. At indicated times, 11 μL of 2% (w/v) saponin solution was added to each well and incubated for 15 min on ice. Samples were sheared using a 1 mL syringe with a blunt needle and bacteria were enumerated by dilution on tryptic soy agar (TSA) following overnight incubation at 37°C with 5% CO~2~.

Plasma Membrane Damage {#S4.SS6}
----------------------

Propidium iodide (PI) uptake was used as a measure of plasma membrane permeability to assess damage of neutrophils by secreted *S. aureus* proteins as described ([@B32], [@B31]; [@B10]). Briefly, bacterial strains were cultured at 37°C for 5 h with shaking (250 RPM) in TSB. After, 1 × 10^9^ CFUs of bacteria were collected and centrifuged for 5 min at 8,000 × g. Supernatants were sterile-filtered and diluted (as indicated in figure legends) with DPBS and exposed to neutrophils for 1 h at 37°C with 5% CO~2~. After incubation, cells were stained with 0.5 μL PI (1 mg mL^--1^ Life Technologies) and analyzed by flow cytometry on a FACS Calibur flow cytometer (BD Biosciences; Franklin Lakes, New Jersey). Neutrophil membrane damage was also assessed by flow cytometry using whole bacteria. For these experiments, neutrophils were exposed to live bacteria (MOI 5:1) and incubated for 3 h at 37°C with 5% CO~2~.

Transcriptional Analysis of Target Genes {#S4.SS7}
----------------------------------------

TaqMan® gene expression experiments were performed as previously described ([@B43], [@B44]; [@B33]). Relative quantification of *S. aureus* target genes was determined by the change in expression of target transcripts normalized to that of the housekeeping gene \[gyrase B (*gyrB*)\] and relative to USA300 LAC transcript levels. Primer/probe sequences are described in [Table 1](#T1){ref-type="table"} ([@B44]; [@B33]). Where indicated, transcript abundance was also measured using SYBR Green chemistry and the absolute transcript abundance method as indicated and as described in [@B28].

Western Blot Analysis {#S4.SS8}
---------------------

Supernatants from overnight cultures in TSB without supplemented glucose were harvested as described above, total protein was measured (Pierce BCA Protein Assay) and adjusted to 500 μg mL^--1^. Samples (14 μL) were resolved using 12% SDS-PAGE gels, (100 V for 45 min) and transferred onto nitrocellulose (at 10 mAmps overnight). Membranes were washed and blocked in DPBS containing 5% (w/v) milk solution for 1 h followed by incubation with rabbit anti-LukS-PV primary antibody (abcam; Cambridge, MA, United States) at a concentration of 0.6 μg mL^--1^ (4 h at 4°C). PVL was detected after 1 h incubation with goat anti-rabbit IgG coupled to horseradish peroxidase (at 1:10,000 dilution) (Jackson ImmunoResearch; West Grove, PA, United States) and developed using 5 mL 3,3′,5,5′-tetramethylbenzidine (TMB) substrate. Images were taken with an Gel Doc Imager (ProteinSimple; San Jose, CA, United States) and analyzed by ImageJ densitometry software ([@B38]).

GFP Reporter Assays With HNP-1 {#S4.SS9}
------------------------------

Bacteria were grown to exponential phase (OD~600~ ∼ 0.6--0.8) as described previously ([@B45]) in 250 ml DeLong flasks containing dilute Luria broth ([@B12]) (5:1 flask:medium ratio) with vigorous shaking (280 RPM) at 37°C in a water bath. Cultures were diluted to a starting OD~600~ ∼ 0.1 in fresh medium and aliquoted into individual wells of a 96 well plate (cultures of 200 μl each) and incubated in a computer controlled Tecan F200 plate reader at 37°C. The optical density at 600 nm (OD~600~) and GFP fluorescence (485 nm excitation, 535 nm emission) values were read every 15 min after shaking (15 s, 2 mm amplitude). When OD~600~ values reached ∼0.4, the plate was removed, and the indicated wells were spiked with 5 μg ml^--1^ of the human neutrophil peptide-1 (HNP-1) or vehicle and returned to the plate reader. Data acquisition continued for an additional 12 h. Mean ± SEM relative fluorescence units (RFUs; GFP fluorescence/OD~600~) from three independent experiments are reported.

Mouse Infection Models {#S4.SS10}
----------------------

### Skin and Soft-Tissue Infection (SSTI) {#S4.SS10.SSS1}

All studies conformed to NIH guidelines and were approved by the Institutional Animal Care and Use Committee at Montana State University. Female C57BL/6 mice (12 weeks old) were purchased from Charles River Laboratories and maintained at the Animal Resources Center at Montana State University. Female and male BALB/C mice were purchased from the Animal Resources Center at Montana State University. *S. aureus* strains: USA300 LAC, and isogenic mutants USA300Δ*saeP*, USA300Δ*saeQ*, USA300Δ*saePQRS*, USA300Δ*saePQ* strains were grown to mid-exponential phase, washed twice with sterile DPBS and resuspended in DPBS at a concentration of 1 × 10^7^ cells per 50 μL. The dose was confirmed by plating serial dilutions on TSA plates For the abscess model, mice (groups of five) were shaved and inoculated with *S. aureus* subcutaneously into the lower back ([@B44]; [@B33]). Infected area was measured using the formula: (l × w).

### Bacteremia Model {#S4.SS10.SSS2}

Experiments were performed following a protocol approved by the Animal Care and Use Committee at Georgetown University (GUACUC). *S. aureus* strains were grown to exponential phase in 250 ml DeLong shake flasks (5:1 flask: medium ratio), harvested at OD~600~ ∼0.4--0.6, washed twice in sterile phosphate buffer saline (PBS), and resuspended to an appropriate optical density equivalent to 1 × 10^8^ colony forming units (CFUs) ml^--1^. Groups of female C57BL/6 mice (6--8-weeks old, purchased from Charles River Laboratories) were infected intravenously via the tail vein with ∼1 × 10^7^ cells in 100 μl of sterile PBS. The dose was confirmed by plating serial dilutions on TSA plates. Animals were monitored twice daily and evaluated following a GUACUC-approved scoring rubric. Infections were allowed to progress for 72 h or until humane endpoints were reached.

To analyze *nuc-gfp* expression in tissues, infections were performed as described for USA300 LAC and the Δ*saePQ* double mutant essentially described above (and specifically in [@B2]); notably, animals were fed AIN-93 purified diet ([@B37]). Briefly, mice were euthanized 72 h post-infection and kidneys were harvested, fixed with 10% (v/v) buffered formalin, embedded in Sub Xero clear tissue freezing medium (Mercedes Medical), and sectioned into 10 μm slices. Sections were mounted with 4′,6-diamidino-2-phenylindole (DAPI) stain and imaged using laser confocal scanning microscopy. Images were processed using ImageJ ([@B38]). Excitation wavelengths for the fluorescence channels are as follows: DAPI, 405 nm; GFP, 488 nm. Emitted fluorescence data were collected over the following ranges of wavelengths: DAPI, 419--481 nm, GFP, 505--551 nm.

Statistics {#S4.SS11}
----------

Statistical analyses were performed using GraphPad Prism version 8.0 (GraphPad Software, La Jolla, CA, United States) with *t*-tests and ANOVA as indicated. Error bars represent the standard error of the mean (SEM).
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###### 

Complementation of *saeP* and *saeQ* restores USA300 phenotype. Gene complementation with *saeP* and *saeQ* on the xylose-inducible pEPSA5 plasmid restores USA300 phenotype. Promoter expression induced with 2% (w/v) xylose in the medium. **(A)** Gene expression of *saeP* and *saeQ* is rescued in *S. aureus* mutant strains complemented with *saeP or saeQ* expressed in trans. **(B)** Complementation of *saeP* restores transcript of select *S. aureus* genes to levels observed in USA300 (or higher). Transcript abundance is relative to *gyrB* and calibrated to expression in USA300 (*n* = 2/gene). **(C)** Complementation of *saeP* and *saeQ* in trans reduces secreted cytolytic factors that target neutrophil plasma membrane damage to levels secreted by USA300. Data are presented as the mean ± SEM of four independent experiments. Stats: One-Way ANOVA with Tukey's post-test; ns, not significant.

###### 

Click here for additional data file.

###### 

Deletion of *saeP* or *saeQ* did not significantly impact abscess area. Deletion of *saeP* or *saeQ* did not significantly impact abscess area. **(A)** BALB/C mice (5 per group) and **(B)** C57BL/6 mice (5 per group) were infected subcutaneously with 1 × 10^7^ CFUs of each *S. aureus* strain and abscess area was subsequently monitored for 10 days. Abscess area was measured daily and results shown are the average area per strain. Representative images are from C57BL/6 mice on day 2. Graphs represent data from two biological replicates for BALB/c and one for C57BL/6. Unpaired *t*-test relative to USA300, ^∗^*p*-value ≤ 0.05, ^∗∗^*p*-value ≤ 0.01. Data are presented as the mean ± SEM.
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Click here for additional data file.

###### 

The Δ*saePQ* mutant has reduced *saeR/S* transcript levels but induces Sae-dependent genes normally. **(A,B)** Normalized transcript abundance is shown for USA300 and the indicated mutant strains of *S. aureus* grown to exponential phase using SYBR green qRT-PCR as described in Materials and Methods and as described in [@B28]. Data indicate the mean ± SEM from three independent experiments. Statistical analysis: ANOVA (ordinary one-way), Dunnett's multiple comparison test, asterisks indicate the level of significance compared to the USA300 (*P* ≤ 0.05). For USA300Δ*saePQRS*, the transcript level is below the limit of detection. **(C)** The indicated strains carrying a *nuc-gfp* reporter fusion were grown to exponential phase (OD~600~ ∼ 0.4) in dilute Luria broth, at which time bacteria were exposed to either vehicle (water) or HNP-1 for 12 h. The data shown are the mean relative fluorescence units (RFUs; fluorescence/OD~600~) ±SEM for three independent experiments performed in technical triplicate; statistical significance was assessed by paired *t*-test (^∗^*P* ≤ 0.05, ^∗∗^*P* ≤ 0.01, ^∗∗∗^*P* ≤ 0.001). ND, not detected: signal was below the limit of detection.
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Click here for additional data file.

###### 

Deletion of *saePQ* influences lesion structure and *nuc* expression in infected kidneys. **(A--F)** Representative confocal micrographs of staphylococcal lesions in kidney produced by USA300 and USA300Δ*saePQ*. Channels: *nuc-sGFP* **(A,D)**, DAPI **(B,E)**, and merge **(C,F)** (scale bar is 25 μm). The fluorescence image acquisition parameters used are as follows; excitation for DAPI (blue) and GFP (green) are 405 and 488 nm respectively; emission ranges are 419--481 nm (DAPI) and 505--551 nm (GFP).
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Click here for additional data file.
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